Articles by M. Lajer (4)

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril

S. E. Nielsen, K. J. Schjoedt, A. S. Astrup, L. Tarnow, M. Lajer, P. R. Hansen, H.-H. Parving and P. Rossing

Diabetic Medicine 27 ( 10 ): 1144 - 1150 , 2010

Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy

S. Theilade, M. Lajer, A. Jorsal, L. Tarnow, H.-H. Parving and P. Rossing

Diabetic Medicine 29 ( 3 ): 337 - 344 , 2012

Arterial stiffness and endothelial dysfunction independently and synergistically predict cardiovascular and renal outcome in patients with type 1 diabetes

S. Theilade, M. Lajer, A. Jorsal, L. Tarnow, H.-H. Parving and P. Rossing

Diabetic Medicine 29 ( 8 ): 990 - 994 , 2012

Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus

M. J. Pena, H. J. Lambers Heerspink, M. E. Hellemons, T. Friedrich, G. Dallmann, M. Lajer, S. J. L. Bakker, R. T. Gansevoort, P. Rossing, D. de Zeeuw and S. S. Roscioni

Diabetic Medicine 31 ( 9 ): 1138 - 1147 , 2014

Do you have a suggestion for journals

Suggest Journal